Sermorelin Reconstitution Chart (Every Vial Size)

Overview of Sermorelin in Preclinical Research

Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment (1-29) of endogenous growth hormone-releasing hormone (GHRH). In preclinical research, this bioactive fragment retains full receptor binding affinity for the GHRH receptor (GHRH-R) located on pituitary somatotropes. Investigators routinely utilize sermorelin in cell culture systems and animal models to examine signal transduction pathways, somatotroph responsiveness, downstream insulin-like growth factor-1 (IGF-1) gene expression, and pulsatile peptide secretion profiles.

To maintain assay reproducibility across diverse experimental protocols, laboratory personnel must achieve exact target concentrations during initial sample preparation. Lyophilized peptides require controlled reconstitution with dedicated laboratory diluents before introduced to in vitro assays or preclinical test setups. PX1 Research supplies highly purified sermorelin within our broader all peptides catalog, ensuring that every lot meets rigorous purity and mass balance specifications required for high-throughput screening and biochemical analysis.

Sermorelin Reconstitution Mathematical Principles

Calculating the final concentration of a reconstituted peptide solution requires a fundamental mass-volume equation. The general expression defining the final concentration ($C$) in milligrams per milliliter (mg/mL) is $C = M / V$, where $M$ represents the total peptide mass in milligrams contained within the vial, and $V$ represents the total volume of added diluent in milliliters.

To convert total concentration into smaller volumetric increments—such as the amount of active peptide present per 0.1 mL (10 units on a standard 100-unit/mL volumetric laboratory syringe)—multiply the final mg/mL concentration by 0.1. For instance, a reconstituted solution with a final concentration of 2.0 mg/mL yields exactly 0.20 mg (200 micrograms) per 0.1 mL volumetric draw. Researchers can also streamline complex benchtop liquid calculations using our interactive automated reconstitution calculator.

Comprehensive Sermorelin Reconstitution Chart

The matrix below outlines the resulting concentrations across standard sermorelin vial masses (2 mg, 5 mg, 10 mg, and 15 mg) when reconstituted with varying diluent volumes of Bacteriostatic Water (0.9% Benzyl Alcohol) or Sterile 0.9% Sodium Chloride.

| Vial Size (Mass) | Diluent Volume Added | Resulting Concentration (mg/mL) | Peptide Content per 0.1 mL Volumetric Draw | |---|---|---|---| | 2 mg | 1.0 mL | 2.00 mg/mL | 0.20 mg (200 mcg) | | 2 mg | 2.0 mL | 1.00 mg/mL | 0.10 mg (100 mcg) | | 2 mg | 3.0 mL | 0.67 mg/mL | 0.067 mg (67 mcg) | | 5 mg | 1.0 mL | 5.00 mg/mL | 0.50 mg (500 mcg) | | 5 mg | 2.5 mL | 2.00 mg/mL | 0.20 mg (200 mcg) | | 5 mg | 5.0 mL | 1.00 mg/mL | 0.10 mg (100 mcg) | | 10 mg | 2.0 mL | 5.00 mg/mL | 0.50 mg (500 mcg) | | 10 mg | 4.0 mL | 2.50 mg/mL | 0.25 mg (250 mcg) | | 10 mg | 5.0 mL | 2.00 mg/mL | 0.20 mg (200 mcg) | | 15 mg | 3.0 mL | 5.00 mg/mL | 0.50 mg (500 mcg) | | 15 mg | 5.0 mL | 3.00 mg/mL | 0.30 mg (300 mcg) | | 15 mg | 7.5 mL | 2.00 mg/mL | 0.20 mg (200 mcg) |

This volumetric data matrix provides immediate benchmark reference points for preparing working stock solutions, preventing mathematical errors during series dilution or microplate administration.

Worked Calculations for Laboratory Sample Preparation

Worked Example 1: Preparing a 1.0 mg/mL stock solution from a 2 mg vial. A laboratory technician selects a 2 mg vial of lyophilized sermorelin acetate. Applying $V = M / C$, to achieve a target concentration of $C = 1.0 \text{ mg/mL}$, the required volume is $V = 2 \text{ mg} / 1.0 \text{ mg/mL} = 2.0 \text{ mL}$. Using a sterile laboratory transfer pipette or syringe, 2.0 mL of Bacteriostatic Water is introduced. Every 0.1 mL aliquot drawn from this reconstituted stock contains exactly 0.1 mg (100 mcg) of sermorelin.

Worked Example 2: Preparing a 2.0 mg/mL stock solution from a 5 mg vial. An investigator requires a working concentration of 2.0 mg/mL for an in vitro microplate receptor binding assay. $V = 5 \text{ mg} / 2.0 \text{ mg/mL} = 2.5 \text{ mL}$. Injecting 2.5 mL of diluent into the 5 mg lyophilized vial yields a final concentration of 2.0 mg/mL. A 0.05 mL (50 microliter) volumetric sample supplies exactly 0.10 mg (100 mcg) of active compound.

Diluent Selection Criteria: Bacteriostatic Water vs. Sterile Saline

Selecting the appropriate solvent for sermorelin reconstitution depends primarily on the designed experimental timeframe and storage protocol. For multi-use laboratory vials that will be sampled repeatedly across extended research windows (up to 28 days under refrigeration), Bacteriostatic Water (0.9% benzyl alcohol preservative) is the standard industry choice. The inclusion of 0.9% benzyl alcohol suppresses potential bacterial growth introduced during repeated septum penetrations.

For immediate, single-use cellular assays or alcohol-sensitive in vitro protocols where benzyl alcohol might interfere with cell line viability, Sterile 0.9% Sodium Chloride Injection or Sterile Water for Injection (WFI) is recommended. However, reconstituted solutions lacking preservative agents exhibit zero antimicrobial inhibition and should be consumed immediately or aliquoted and stored frozen at -20°C or -80°C to prevent degradation and contamination.

Standardized Laboratory Aseptic Reconstitution Protocol

Step 1: Sanitize the laboratory benchtop surface with 70% isopropyl alcohol. Allow the sealed glass vial of lyophilized sermorelin acetate and the chosen diluent to equilibrate to ambient laboratory temperature (20°C to 22°C) prior to liquid introduction.

Step 2: Remove the flip-off plastic cap from the vial and thoroughly wipe the rubber stopper with a sterile 70% isopropyl alcohol swab. Allow the stopper to air dry completely to avoid alcohol carryover into the vial.

Step 3: Using a sterile volumetric laboratory syringe, draw the exact measured volume of diluent (e.g., 2.0 mL). Position the needle tip against the inner glass wall of the vial so that the liquid streams slowly down the side wall rather than directly onto the lyophilized peptide cake.

Step 4: Release any internal vacuum or positive pressure by equilibrating the headspace gas volume. Gently swirl the vial in a smooth circular motion until the cake is fully dissolved. Never shake the vial vigorously, as severe mechanical agitation and shearing forces can disrupt delicate secondary structures and cause peptide aggregation.

Storage Parameters and Degradation Prevention

Lyophilized sermorelin acetate exhibits high stability when preserved in desiccated conditions at -20°C. Protect the sealed powder from light exposure to prevent photo-oxidation of susceptible residue side chains. Under these cold storage parameters, un-reconstituted research vials remain stable for extended study durations.

Once reconstituted with preserved Bacteriostatic Water, the liquid stock solution should be stored under refrigeration at 2°C to 8°C. Do not store reconstituted liquid at ambient room temperature. If long-term storage of reconstituted sermorelin is necessary, aliquot the stock solution into single-use polypropylene microcentrifuge tubes and store at -80°C to avoid repeated freeze-thaw cycles. Complete analytical verification details for storage integrity are listed on every lot-specific certificate of analysis.

Comparative Analysis: Sermorelin vs. Related GHRH Analogues

Within preclinical secretagogue evaluation, sermorelin is routinely compared against other synthetically modified growth hormone-releasing hormone peptides to map binding kinetics and biological half-life variations. While sermorelin represents the truncated 29-amino-acid native sequence, tesamorelin incorporates a trans-3-hexenoic acid group attached to the N-terminal residue, significantly altering its resistance to dipeptidyl peptidase-4 (DPP-IV) enzymatic cleavage.

In contrast, non-GHRH secretagogues such as ipamorelin operate via an entirely distinct receptor family—specifically the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Meanwhile, compounds like cjc-1295-no-dac utilize structural substitutions at positions 2, 8, 15, and 27 to extend systemic exposure in animal models compared to standard sermorelin.

Analytical Purity Verification and Quality Control

PX1 Research enforces ultra-strict quality control parameters for all research compounds supplied to academic institutions, biotechnology firms, and analytical facilities. Every production lot of sermorelin undergoes comprehensive identity and purity testing via high-performance liquid chromatography (HPLC) combined with mass spectrometry (MS) to verify molecular mass (3458.0 Da) and structural integrity.

In addition to chromatography verification exceeding 99% purity, PX1 products undergo USP <85> bacterial endotoxin testing to guarantee endotoxin levels remain strictly under <0.01 EU/mg. All manufacturing takes place in ISO 17025 accredited, GMP-compliant facilities located in the USA, with inventory dispatched directly from CA and AZ hubs. Researchers can review structural data and analytical methodologies in our technical research portal.

Institutional Procurement and Wholesale Accounts

Principal investigators and laboratory managers requiring high-volume supplies of research-grade peptides for long-term preclinical trials can establish bulk supply chains. PX1 Research provides volume tiering, dedicated lot reservation, and batch-matched consistency across large scale orders.

To apply for institutional ordering status, review specialized volume pricing schedules, or submit custom synthesis requests, submit an inquiry through our direct wholesale portal.